TITLE

The Debate Over: Stem Cells Gets Hot

AUTHOR(S)
D'Agnese, Joseph
PUB. DATE
January 2002
SOURCE
Discover;Jan2002, Vol. 23 Issue 1, p56
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the controversy over stem cell research in the United States. Advantages in using embryonic stem cells; Funds granted to stem cells research; Sufficiency of embryos in medical treatment. INSETS: NEWS FROM THE WORLD OF ADULT STEM-CELL RESEARCH.;NEWS OF EMBRYONIC STEM CELLS.;A REVERSE BRAIN DRAIN?.
ACCESSION #
5800963

 

Related Articles

  • DESIGNING AN EFFECTIVE PROGRAM OF STATE-SPONSORED HUMAN EMBRYONIC STEM CELL RESEARCH. Noll, Roger G. // Berkeley Technology Law Journal;Summer2006, Vol. 21 Issue 3, p1143 

    The article discusses the methods of establishing an effective program of state-sponsored human embryonic stem cell research as depicted in the creation of the California Institute for Regenerative Medicine. One of the methods is the elimination of "pork barrel" effects on the funding for these...

  • FROM THE LAB.  // Medical Technology & Devices Week;2/26/2007, Vol. 5 Issue 9, p1 

    The article reports on the awarding of the Scientific Excellence through Exploration and Development (SEED) Grants to several human embryonic stem cell (hESC) studies in California. The Independent Citizens Oversight Committee (ICOC), governing board of the California Institute for Regenerative...

  • Stem Cell Suicide. Davies, Kevin // Bio-IT World;Jul2003, Vol. 2 Issue 7, p6 

    Offers updates on the state of embryonic stem cell research despite funding restrictions issued by the U.S. government, as of July 2003. Breakthroughs in the field of embryonic stem cell research; Pledge made by National Institutes of Health Director Elias Zerhouni to help improve stem cell...

  • California Embryonic Stem Cell Research Agency Will Issue Bonds.  // National Right to Life News;Jun2007, Vol. 34 Issue 6, p7 

    The article reports on the plan of the California Institute for Regenerative Medicine to issue bonds to fund embryonic stem cell research in the state. The proceeds of the first sale of the bond will be used to repay the loans made by the institute during the lawsuits and to fund more research...

  • "CIRM Awards $25 Mln To Support Spinal-Cord Injury Trial, $37.7 Mln for Basic Stem-Cell Science".  // Biomedical Market Newsletter;5/9/2011, p143 

    The article reports that the Governing Board of the California Institute for Regenerative Medicine (CIRM), the State Stem Cell Agency, has approved a grant worth 25 million dollars to support the first U.S. Food & Drug Administration (FDA)-approved clinical trial based on cells derived from...

  • $2.52 million grant work to use ACTC ACTcellerate technology.  // Medical Device Daily;3/21/2007, Vol. 11 Issue 54, p3 

    The article reports on a grant awarded to scientist Randall Lee to fund pre-clinical studies using human embryonic stem cells (HESC) derived from Advanced Cell Technology's proprietary ACTcellerate technology. The research aims to determine if HESC are safe and effective in animal models for...

  • U.S. stem cell researchers confront uncertain financing and arcane restrictions. Mann, Charles C. // Technology Review;Sep2005, Vol. 108 Issue 9, p44 

    The article focuses on the dilemma faced by stem cell researchers in line with the decision of the U.S. government to prohibit the use of federal money for stem cell research. On August 9, 2001, U.S. President George W. Bush was addressing the nation about embryonic-stem-cell-research....

  • US health officials rally behind bid to relax rules on embryo research. Check, Erika // Nature;4/14/2005, Vol. 434 Issue 7035, p809 

    Reports that officials at the U.S. National Institutes of Health (NIH) have lobbied lawmakers to loosen rules governing federal funding for human embryonic stem-cell research. Arguments against the president George W. Bush's policy to limit stem cell research; Importance of access to more cells...

  • Divergent local laws threaten to stifle Europe's stem-cell project. Schiermeier, Quirin // Nature;4/14/2005, Vol. 434 Issue 7035, p809 

    Reports that divergent local laws could delay a high-profile collaboration in human embryonic stem-cell research in the European Union. Concern over the ethical implications of using embryonic stem cells because it requires the destruction of human embryos; Observation that stem-cell research...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics